SynCore Biotechnology Co

SynCore Biotechnology Co Equity Growth

The Year-over-Year Equity Growth of SynCore Biotechnology Co (4192.TWO) as of Nov 17, 2026 is -16.65 %. In the previous year, Year-over-Year Equity Growth was -17.49 % — a change of -4.79% (higher).

Equity Growth

-16.65 %

YoY

-4.79%

Last updated:

Year-over-Year Equity Growth of SynCore Biotechnology Co is 2025 -16.65 % . Year-over-Year Equity Growth of SynCore Biotechnology Co was 2024 -17.49 % . It decreases by -4.79% higher compared to the previous year.

The SynCore Biotechnology Co Equity Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Growth
Date
Equity Growth
Jan 1, 2018
-1.93 TWD
Jan 1, 2019
-13.40 TWD
Jan 1, 2020
-8.41 TWD
Jan 1, 2021
-20.99 TWD
Jan 1, 2022
-43.78 TWD
Jan 1, 2023
43.42 TWD
Jan 1, 2024
-17.49 TWD
Jan 1, 2025
-16.65 TWD
The SynCore Biotechnology Co Equity Growth history
YEAREquity GrowthYoY
-16.65 %-4.79%
-17.49 %-140.27%
43.42 %-199.18%
-43.78 %+108.58%
-20.99 %+149.67%
-8.41 %-37.24%
-13.40 %+593.55%
-1.93 %-92.40%
-25.43 %-273.48%
14.66 %-343.78%
-6.01 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SynCore Biotechnology Co Stock analysis

What does SynCore Biotechnology Co do? SynCore Biotechnology Co Ltd, based in Dongshan, Yilan, Taiwan, operates in the Health Care sector with a focus on Pharmaceuticals. The company develops new drugs and integrates technology, employing 50 full-time staff. Its main product is SB03 Veregen, alongside research and development of anticancer drugs SB01 (injection and oral forms). SynCore primarily distributes its products within Taiwan. SynCore Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SynCore Biotechnology Co stock

Year-over-Year Equity Growth of SynCore Biotechnology Co is -16.65 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year Equity Growth SynCore Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

Equity growth measures the percentage change in shareholders' equity. It reflects retained earnings, share issuances, and comprehensive income effects.

To evaluate Year-over-Year Equity Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Equity Growth.

Year-over-Year Equity Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Equity Growth's SynCore Biotechnology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — SynCore Biotechnology Co

All Key Metrics — SynCore Biotechnology Co